These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6702755)

  • 41. Survey of the current status of the clinical uses of antilymphocyte serum.
    Monaco AP; Codish SD
    Surg Gynecol Obstet; 1976 Mar; 142(3):417-26. PubMed ID: 766248
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antilymphocyte globulin for the treatment of steroid non-responsive acute renal allograft rejection.
    Griffin PJ; Williams GT; Salaman JR
    Clin Nephrol; 1984 Feb; 21(2):115-7. PubMed ID: 6373078
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Improvement in cyclosporine handling by anti-lymphocyte globulin in the early post-operative period.
    Grundmann R; Wienand P; Hesse U
    Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985; 21():987-91. PubMed ID: 3887394
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunologic monitoring parameters in ALG- versus non-ALG-treated renal transplant patients.
    McAlack RF; Stern S; Beizer R; Sklar L; Bannett A
    Transplant Proc; 1979 Jun; 11(2):1431-2. PubMed ID: 382532
    [No Abstract]   [Full Text] [Related]  

  • 45. Paradoxical findings in direct antiglobulin test and classification of agglutinating autoantibodies using eluates and monospecific anti-human globulin sera.
    Bartolmäs T; Mayer B; Yürek S; Genth R; Salama A
    Vox Sang; 2015 Jan; 108(1):58-63. PubMed ID: 25130988
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Positive direct Coombs' test in acute leukemias and other hemoblastoses: relation to clavulanic acid-containing antibiotics?].
    Blanchard M; Oppliger R; Bucher U
    Schweiz Med Wochenschr; 1989 Jan; 119(2):39-45. PubMed ID: 2916108
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Causes of allograft failure in recipients treated with and without antilymphocyte globulin.
    Sheil AG; May J; Rogers JH; Storey BG; Katran DC; Duggin GG; Johnson JR; Stewart JH
    Transplant Proc; 1973 Mar; 5(1):561-5. PubMed ID: 4121179
    [No Abstract]   [Full Text] [Related]  

  • 48. A prospective randomized controlled trial of initial immunosuppression with ALG versus OKT3 in recipients of cardiac allografts.
    Menkis AH; Powell AM; Novick RJ; McKenzie FN; Kostuk WJ; Pflugfelder PW; Brown JE; Rochon J; Chow LH; Stiller C
    J Heart Lung Transplant; 1992; 11(3 Pt 1):569-76. PubMed ID: 1610866
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of antimouse and antihorse antibody production during the treatment of allograft rejection with OKT3 or antithymocyte globulin.
    Shield CF; Norman DJ; Marlett P; Fucello AJ; Goldstein G
    Nephron; 1987; 46 Suppl 1():48-51. PubMed ID: 3306425
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Results of severe aplastic anemia treated with antilymphocytic globulin].
    Morales-Polanco MR; Pizzuto-Chávez J; Izquierdo-Ramírez J; Farfán-Canto JM
    Gac Med Mex; 1989; 125(3-4):97-101; discussion 102-4. PubMed ID: 2633949
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of prophylaxis with low-dose anti-thymocyte globulin on prevention of acute kidney allograft rejection.
    Khosroshahi HT; Tubbs RS; Shoja MM; Ghafari A; Noshad H; Ardalan MR
    Transplant Proc; 2008; 40(1):137-9. PubMed ID: 18261569
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Randomized controlled trial of a monoclonal antibody against the interleukin-2 receptor (33B3.1) as compared with rabbit antithymocyte globulin for prophylaxis against rejection of renal allografts.
    Soulillou JP; Cantarovich D; Le Mauff B; Giral M; Robillard N; Hourmant M; Hirn M; Jacques Y
    N Engl J Med; 1990 Apr; 322(17):1175-82. PubMed ID: 2157982
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antilymphoblast globulin in renal transplant patients. No allergic reactions.
    Martin WJ; Blumenthal M; Roitman B; Condie R; Simmons R; Najarian J
    JAMA; 1976 Oct; 236(15):1729-31. PubMed ID: 61287
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical impact of replacing Minnesota antilymphocyte globulin with ATGAM.
    Lum CT; Umen AJ; Kasiske B; Goerdt P; Heim-Duthoy KL; Andersen RC; Odland MD; Ney AL; Jacobs DM; Rao KV
    Transplantation; 1995 Feb; 59(3):371-6. PubMed ID: 7871567
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prediction of long term combined imuran ALG dosage.
    Ollodart RM; Flotte CT; Lubash GD; Young JD; Sadler JH; Ramos E
    Proc Clin Dial Transplant Forum; 1972; 2():8-16. PubMed ID: 4219814
    [No Abstract]   [Full Text] [Related]  

  • 56. [Positive direct antiglobulin test due to anti-C in antilymphocyte globulin following its use in a patient with aplastic anemia].
    Koga S; Nishimura Y; Kawakita M; Nishimura H; Nomura H; Takatsuki K
    Rinsho Ketsueki; 1986 Nov; 27(11):2107-11. PubMed ID: 3820628
    [No Abstract]   [Full Text] [Related]  

  • 57. Potency and maintenance in antilymphocyte globulin fractionation: contrasting tests of effectiveness in an animal model.
    Salerni B; Simmonian SJ; Kay RG; Latham WC; Brown KJ; Birtch AG; Busch GJ; Lukl P; Woods JE
    Surg Forum; 1970; 21():277-9. PubMed ID: 4936983
    [No Abstract]   [Full Text] [Related]  

  • 58. Treatment of severe aplastic anemia with sequential immunosuppression.
    Marmont AM; Bacigalupo A; Van Lint MT; Frassoni F; Risso M; Cerri R; Rossi E; Damasio EE; Santini G; Carella M
    Exp Hematol; 1983 Oct; 11(9):856-65. PubMed ID: 6357828
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of severe aplastic anemia with antilymphocyte globulin, cyclosporine and two different granulocyte colony-stimulating factor regimens: a GITMO prospective randomized study.
    Locasciulli A; Bruno B; Rambaldi A; Saracco P; Dufour C; Finelli C; Sica S; Varotto S; Arcese W; Locatelli F; Soligo D; Bacigalupo A;
    Haematologica; 2004 Sep; 89(9):1054-61. PubMed ID: 15377466
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pretreatment with antilymphocyte globulin and donor cells on graft prolongation in an experimental model and some observations on graft-versus-host reaction.
    Pegrum GD; Williams G; Markwick J; Barnes RM
    Postgrad Med J; 1976; 52(5 Suppl):47-50. PubMed ID: 11454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.